RT Journal Article
T1 Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
A1 Rey, Esther
A1 Ampuero, Javier
A1 Molina-Jiménez, Francisca
A1 Marañón, Patricia
A1 García-García, Yaiza
A1 Múñoz-Hernández, Rocío
A1 Romero-Gómez, Manuel
A1 García-Monzón, Carmelo
A1 Majano, Pedro
A1 González-Rodríguez, Águeda
SN 2001-1326
YR 2021
FD 2021
LK https://hdl.handle.net/10668/27345
UL https://hdl.handle.net/10668/27345
LA en
DS RISalud
RD Apr 6, 2025